--News Direct--

Predictive Oncology CEO Raymond Vennare and Cvergenx CEO Javier Torres-Roca join Natalie Stoberman to share news of their new partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligence (AI).

Vennare said the objective of this collaboration will be to leverage Predictive Oncology’s drug discovery, AI and machine learning capabilities with the Cvergenx precision genomics radiation therapy platform.

Proactive US

+1 347-449-0879

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/predictive-oncology-partners-with-cvergenx-to-create-new-genomics-based-ai-radiation-therapy-151675745